Louise K. Mercer

Stepping Hill Hospital
Stockport, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 21 publications

Aligning monitoring with risk: what the new British Society for Rheumatology guidance means for practice.

Aligning monitoring with risk: what the new British Society for Rheumatology guidance means for practice.

Journal: Rheumatology (Oxford, England)

Published: January 01, 2026

The development of a risk threshold to aid risk stratified approach to monitoring for haematological, hepatic and/or renal adverse drug reactions during established cs DMARD treatment for systemic autoimmune rheumatic diseases: a RAND/UCLA Appropriateness Method consensus study.

The development of a risk threshold to aid risk stratified approach to monitoring for haematological, hepatic and/or renal adverse drug reactions during established cs DMARD treatment for systemic autoimmune rheumatic diseases: a RAND/UCLA Appropriateness Method consensus study.

Journal: Rheumatology (Oxford, England)

Published: August 04, 2025

The 2025 British Society for Rheumatology guideline for the prescription and monitoring of conventional synthetic disease-modifying anti-rheumatic drugs.

The 2025 British Society for Rheumatology guideline for the prescription and monitoring of conventional synthetic disease-modifying anti-rheumatic drugs.

Journal: Rheumatology (Oxford, England)

Published: May 08, 2025

Coming to a hard stop? Effect of tapered tocilizumab after weekly tocilizumab cessation for GCA: a multicentre evaluation.

Coming to a hard stop? Effect of tapered tocilizumab after weekly tocilizumab cessation for GCA: a multicentre evaluation.

Journal: Rheumatology (Oxford, England)

Published: February 05, 2025

The prescription and monitoring of conventional synthetic disease-modifying anti-rheumatic drugs: British Society for Rheumatology guideline scope.

The prescription and monitoring of conventional synthetic disease-modifying anti-rheumatic drugs: British Society for Rheumatology guideline scope.

Journal: Rheumatology advances in practice

Published: February 27, 2024

Relapse after cessation of weekly tocilizumab for giant cell arteritis: a multicentre service evaluation in England.

Relapse after cessation of weekly tocilizumab for giant cell arteritis: a multicentre service evaluation in England.

Journal: Rheumatology (Oxford, England)

Published: June 28, 2023

Prevalence of adverse childhood experiences and associations with personal and professional factors in health and social care workers: A systematic review.

Prevalence of adverse childhood experiences and associations with personal and professional factors in health and social care workers: A systematic review.

Journal: Psychological trauma : theory, research, practice and policy

Published: May 04, 2023

Burnout and secondary traumatic stress in staff working with people with intellectual disabilities: The role of adverse childhood experiences, resilience and trauma-informed organisational climate.

Burnout and secondary traumatic stress in staff working with people with intellectual disabilities: The role of adverse childhood experiences, resilience and trauma-informed organisational climate.

Journal: Journal of applied research in intellectual disabilities : JARID

Published: October 29, 2022

Malignancy and mortality rates in patients with severe psoriatic arthritis requiring tumour-necrosis factor alpha inhibition: results from the British Society for Rheumatology Biologics Register.

Malignancy and mortality rates in patients with severe psoriatic arthritis requiring tumour-necrosis factor alpha inhibition: results from the British Society for Rheumatology Biologics Register.

Journal: Rheumatology (Oxford, England)

Published: March 19, 2018

Spectrum of lymphomas across different drug treatment groups in rheumatoid arthritis: a European registries collaborative project.

Spectrum of lymphomas across different drug treatment groups in rheumatoid arthritis: a European registries collaborative project.

Journal: Annals of the rheumatic diseases

Published: April 10, 2017

Response to: 'Does the risk of lymphoma in patients with RA treated with TNF inhibitors differ according to the histological subtype and the type of TNF inhibitor?' by Nocturne et al.

Response to: 'Does the risk of lymphoma in patients with RA treated with TNF inhibitors differ according to the histological subtype and the type of TNF inhibitor?' by Nocturne et al.

Journal: Annals of the rheumatic diseases

Published: October 03, 2016

Relationship between exposure to tumour necrosis factor inhibitor therapy and incidence and severity of myocardial infarction in patients with rheumatoid arthritis.

Relationship between exposure to tumour necrosis factor inhibitor therapy and incidence and severity of myocardial infarction in patients with rheumatoid arthritis.

Journal: Annals of the rheumatic diseases

Published: April 25, 2016

Showing 1-12 of 21

Last Updated: 09/26/2026